Cure My Disease

Don't miss your cure!

 Log in / Sign up

Eye tracking could revolutionize MS monitoring

NCT ID NCT06733922

Recruiting now Knowledge-focused Sponsor: Novartis Pharmaceuticals Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether a new eye-tracking device can help doctors see how well multiple sclerosis (MS) treatment is working. About 224 Canadian adults with relapsing-remitting MS will use the device during routine care. The goal is to find out if eye movement changes can replace or add to standard tests for tracking the disease.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RELAPSING-REMITTING MULTIPLE SCLEROSIS (RRMS) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Charcot-Marie-Tooth disease type 1F relapsing-remitting multiple sclerosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

RELAPSING-REMITTING MULTIPLE SCLEROSIS (RRMS)

Contacts and locations

Locations

  • Novartis Investigative Site

    RECRUITING

    Calgary, Alberta, T2N 4N1, Canada

  • Novartis Investigative Site

    RECRUITING

    Calgary, Alberta, T3M 1M4, Canada

  • Novartis Investigative Site

    RECRUITING

    Edmonton, Alberta, T6G 2C8, Canada

  • Novartis Investigative Site

    RECRUITING

    Burnaby, British Columbia, V5G 2X6, Canada

  • Novartis Investigative Site

    RECRUITING

    Vancouver, British Columbia, V6T 2A1, Canada

  • Novartis Investigative Site

    RECRUITING

    St. John's, Newfoundland and Labrador, A1B 3V6, Canada

  • Novartis Investigative Site

    RECRUITING

    Halifax, Nova Scotia, B3H 3A7, Canada

  • Novartis Investigative Site

    RECRUITING

    Halifax, Nova Scotia, B3R 1V9, Canada

  • Novartis Investigative Site

    RECRUITING

    Ottawa, Ontario, K1H 8L6, Canada

  • Novartis Investigative Site

    RECRUITING

    Montreal, Quebec, H1K 3V9, Canada

  • Novartis Investigative Site

    RECRUITING

    Montreal, Quebec, H3A 0G4, Canada

  • Novartis Investigative Site

    RECRUITING

    Montreal, Quebec, H4A 3T2, Canada

  • Novartis Investigative Site

    RECRUITING

    Québec, Quebec, G1W 4R4, Canada

  • Novartis Investigative Site

    RECRUITING

    Sherbrooke, Quebec, J1G 2E8, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.